US Patent 8158579 Fusion protein of an exendin to modified transferrin
Patent 8158579 was granted and assigned to BIOREXIS PHARMACEUTICAL CORPORATION on April, 2012 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 8158579 Fusion protein of an exendin to modified transferrin
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.